# Efficacy & Safety Study of Nonracemic Methadone for the Relief of Chronic Peripheral Neuropathic Pain

> **NCT01429181** · PHASE2 · COMPLETED · sponsor: **MetaPharm, Inc.** · enrollment: 37 (actual)

## Conditions studied

- Diabetic Peripheral Neuropathic Pain

## Interventions

- **DRUG:** Non-racemic mixture of methadone HCl

## Key facts

- **NCT ID:** NCT01429181
- **Lead sponsor:** MetaPharm, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2014-09
- **Final completion:** 2014-12
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2017-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01429181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01429181, "Efficacy & Safety Study of Nonracemic Methadone for the Relief of Chronic Peripheral Neuropathic Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01429181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*